Reference
Ye J, et al. Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report. Frontiers in Oncology 12: May 2022. Available from: URL: http://doi.org/10.3389/fonc.2022.883367
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1921, 43 (2022). https://doi.org/10.1007/s40278-022-22037-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-22037-0